Editor’s Choice: <a href="/article/S0090-8258(25)00816-9/abstract">TROP2 expression and therapeutic targeting in uterine carcinosarcoma</a>
Editorial: <a href="/article/S0090-8258(25)00858-3/fulltext">The search for new therapeutic options for uterine carcinosarcoma</a>

Editor’s Choice: TROP2 expression and therapeutic targeting in uterine carcinosarcoma Editorial: The search for new therapeutic options for uterine carcinosarcoma

Editor’s Choice: <a href="/article/S0090-8258(25)00816-9/abstract" rel="noopener noreferrer">TROP2 expression and therapeutic targeting in uterine carcinosarcoma</a>
Editorial: <a href="/article/S0090-8258(25)00858-3/fulltext" rel="noopener noreferrer">The search for new therapeutic options for uterine carcinosarcoma</a>

Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

Listen to the latest news from the experts in your field.

Share Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

Sign up to save your podcasts

Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

More shows like Listen to Gynecologic Oncology

The NPR Politics Podcast

Pod Save America

The Daily

Up First from NPR

SGO on the GO

John Mark Comer Teachings

Good Hang with Amy Poehler